Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 25;11(5):896.
doi: 10.3390/vaccines11050896.

Living with HIV and Getting Vaccinated: A Narrative Review

Affiliations
Review

Living with HIV and Getting Vaccinated: A Narrative Review

Andrea De Vito et al. Vaccines (Basel). .

Abstract

After 40 years of its appearance, human immunodeficiency virus (HIV) infection remains a leading public health challenge worldwide. Since the introduction of antiretroviral treatment (ART), HIV infection has become a chronic condition, and people living with HIV could have life expectancies close to those of the general population. People with HIV often have an increased risk of infection or experience more severe morbidity following exposure to vaccine-preventable diseases. Nowadays, several vaccines are available against bacteria and viruses. However, national and international vaccination guidelines for people with HIV are heterogeneous, and not every vaccine is included. For these reasons, we aimed to perform a narrative review about the vaccinations available for adults living with HIV, reporting the most updated studies performed for each vaccine among this population. We performed a comprehensive literature search through electronic databases (Pubmed-MEDLINE and Embase) and search engines (Google Scholar). We included English peer-reviewed publications (articles and reviews) on HIV and vaccination. Despite widespread use and guideline recommendations, few vaccine trials have been conducted in people with HIV. In addition, not all vaccines are recommended for people with HIV, especially for those with low CD4 cells count. Clinicians should carefully collect the history of vaccinations and patients' acceptance and preferences and regularly check the presence of antibodies for vaccine-preventable pathogens.

Keywords: HAV; HBV; HIV; HPV; MPox; SARS-CoV-2; preventable diseases; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Trickey A., Zhang L., Sabin C.A., Sterne J.A.C. Life expectancy of people with HIV on long-term antiretroviral therapy in Europe and North America: A cohort study. Lancet Healthy Longev. 2022;3:S2. doi: 10.1016/S2666-7568(22)00063-0. - DOI
    1. Deeks S.G., Lewin S.R., Havlir D.V. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382:1525–1533. doi: 10.1016/S0140-6736(13)61809-7. - DOI - PMC - PubMed
    1. Deeks S.G., Phillips A.N. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172. doi: 10.1136/bmj.a3172. - DOI - PubMed
    1. Guaraldi G., Rockwood K. Geriatric-HIV Medicine Is Born. Clin. Infect. Dis. 2017;65:507–509. doi: 10.1093/cid/cix316. - DOI - PubMed
    1. Guaraldi G., Milic J., Mussini C. Aging with HIV. Curr. HIV/AIDS Rep. 2019;16:475–481. doi: 10.1007/s11904-019-00464-3. - DOI - PubMed